Kim Schneider

Kim Schneider is an accomplished scientist with extensive experience in genomics and molecular biology. Currently serving as the Head of Genomics 360 Technology Platform and Genomics 360 Lab at Roche since July 2022, Kim has previously held positions as a Principal Scientist at FoRx Therapeutics and a Senior Scientist at Illumina, focusing on sequencing quality, protein characterization, and library preparation methods. Early career experiences include post-doctoral fellowships at the Medical Research Council and the University of Geneva, where work focused on high-throughput sequencing and cellular metabolism. Kim Schneider earned a PhD in Biology, along with multiple degrees in social sciences from the University of Geneva.